BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11022947)

  • 1. Comparison of losartan and captopril in ELITE II.
    Meyer FP
    Lancet; 2000 Sep; 356(9232):851; author reply 852-3. PubMed ID: 11022947
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of losartan and captopril in ELITE II.
    Hall A
    Lancet; 2000 Sep; 356(9232):851; author reply 852-3. PubMed ID: 11022946
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of losartan and captopril in ELITE II.
    Lye M
    Lancet; 2000 Sep; 356(9232):852; author reply 852-3. PubMed ID: 11022949
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
    Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
    Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All that glitters is not gold.
    Velazquez EJ; Califf RM
    Lancet; 2000 May; 355(9215):1568-9. PubMed ID: 10821355
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of losartan and captopril on QT dispersion in elderly patients with heart failure. ELITE study group.
    Brooksby P; Robinson PJ; Segal R; Klinger G; Pitt B; Cowley AJ
    Lancet; 1999 Jul; 354(9176):395-6. PubMed ID: 10437875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II.
    Pitt B; Poole-Wilson P; Segal R; Martinez FA; Dickstein K; Camm AJ; Konstam MA; Riegger G; Klinger GH; Neaton J; Sharma D; Thiyagarajan B
    J Card Fail; 1999 Jun; 5(2):146-54. PubMed ID: 10404354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interview with the author of ELITE II. Cave: small studies of fatal illnesses].
    Pitt B
    MMW Fortschr Med; 1999 Nov; 141(47):6. PubMed ID: 10912156
    [No Abstract]   [Full Text] [Related]  

  • 10. [ACE inhibitors or AT1 receptor antagonists?].
    Riegger GA
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S37-9. PubMed ID: 10535045
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).
    Konstam MA; Neaton JD; Poole-Wilson PA; Pitt B; Segal R; Sharma D; Dasbach EJ; Carides GW; Dickstein K; Riegger G; Camm AJ; Martinez FA; Bradstreet DC; Ikeda LS; Santoro EP;
    Am Heart J; 2005 Jul; 150(1):123-31. PubMed ID: 16084158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiotensin II antagonist for heart insufficiency].
    Z Kardiol; 1997 Jun; 86(6 Suppl):1-8. PubMed ID: 9259867
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy.
    Cowley AJ; Wiens BL; Segal R; Rich MW; Santanello NC; Dasbach EJ; Pitt B;
    Qual Life Res; 2000; 9(4):377-84. PubMed ID: 11131930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Losartan in the Elderly (ELITE) Trial: clinical implications.
    Pitt B
    Eur Heart J; 1997 Aug; 18(8):1197-9. PubMed ID: 9458406
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current role of angiotensin II antagonists in the treatment of heart failure].
    Porcu M; OrrĂ¹ P
    Ital Heart J Suppl; 2000 Sep; 1(9):1213-4. PubMed ID: 11140296
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of losartan and captopril in ELITE II.
    Gansevoort RT; van Veldhuisen DJ
    Lancet; 2000 Sep; 356(9232):851-2; author reply 852-3. PubMed ID: 11022948
    [No Abstract]   [Full Text] [Related]  

  • 17. Are angiotensin II receptor blockers more efficacious than placebo in heart failure? Implications of ELITE-2. Evaluation of Losartan In The Elderly.
    Berry C; Norrie J; McMurray JJ
    Am J Cardiol; 2001 Mar; 87(5):606-7, A9. PubMed ID: 11230847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan versus captopril in elderly patients with heart failure.
    Ball SG
    Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164338
    [No Abstract]   [Full Text] [Related]  

  • 19. Losartan versus captopril in elderly patients with heart failure.
    Sechi LA; Catena C; Bartoli E
    Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164337
    [No Abstract]   [Full Text] [Related]  

  • 20. Losartan versus captopril in elderly patients with heart failure.
    Jensen BV; Nielsen SL
    Lancet; 1997 May; 349(9063):1473; author reply 1475. PubMed ID: 9164335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.